Company Filing History:

8 out of 321

Korea Research Institute of Bioscience and Biotechnology

patents

2 out of 623

Korea Research Institute of Chemical Technology

patents

2 out of 2

Jeil Pharm. Co., Ltd.

where one patent can have more than one assignee

Years Active: 2002-2013

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8394799 - Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component (2013-03-12),

2. 7745439 - Indene derivatives and process for the preparation thereof (2010-06-29),

3. 7741323 - Indene derivatives and process for the preparation thereof (2010-06-22),

4. 7718202 - Method for treating erectile dysfunction with acantopanax extract (ogalpi) (2010-05-18),

5. 7309504 - [object Object] (2007-12-18),

6. 6894073 - Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer (2005-05-17),

7. 6770671 - 7,8-dihydro-xanthenone-8-carboxylic acid derivative and novel microbe producing the same (2004-08-03),

8. 6451846 - Isocoumarin derivatives inhibiting angiogenesis (2002-09-17),

Title: The Innovative Contributions of Jeong-Hyung Lee

Introduction

Jeong-Hyung Lee is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of biotechnology and pharmaceuticals, holding a total of eight patents. His work primarily focuses on developing compounds that have therapeutic applications in treating various diseases, including cancer and metabolic disorders.

Latest Patents

Among his latest patents is a groundbreaking HIF-1 inhibitor, which demonstrates anticancer activity by inhibiting HIF-1, a transcription factor crucial for cancer growth and metastasis. This invention not only shows promise in treating various cancers, such as liver, stomach, and breast cancer, but also has potential applications in treating diabetic retinopathy and arthritis. Another notable patent involves indene derivatives that selectively modulate the activities of peroxisome proliferator-activated receptors (PPARs). These derivatives are beneficial for treating metabolic syndromes, inflammatory diseases, and cancer without causing adverse side effects.

Career Highlights

Jeong-Hyung Lee has worked with esteemed institutions such as the Korea Research Institute of Bioscience and Biotechnology and the Korea Research Institute of Chemical Technology. His research has significantly advanced the understanding of therapeutic compounds and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Jung Joon Lee and Young-Soo Hong, contributing to a rich environment of innovation and research.

Conclusion

Jeong-Hyung Lee's innovative work in developing therapeutic compounds has the potential to make a lasting impact on the medical field. His contributions continue to pave the way for advancements in cancer treatment and metabolic disorder management.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.